Published in Sex Transm Dis on March 01, 2008
Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity. PLoS One (2008) 1.57
A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy. J Control Release (2015) 1.55
Vaginal drug delivery systems for HIV prevention. AAPS J (2009) 1.51
An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques. PLoS One (2011) 1.35
Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge. Antimicrob Agents Chemother (2011) 1.23
Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice. Trends Microbiol (2012) 1.15
The nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques. J Virol (2011) 1.07
A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV. PLoS One (2014) 1.07
Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus. Antiviral Res (2009) 1.04
Iota-carrageenan is a potent inhibitor of influenza A virus infection. PLoS One (2010) 1.04
Selection of a simian-human immunodeficiency virus strain resistant to a vaginal microbicide in macaques. J Virol (2009) 1.01
Role of heparan sulfate in sexually transmitted infections. Glycobiology (2012) 0.98
Expanded safety and acceptability of the candidate vaginal microbicide Carraguard® in South Africa. Contraception (2010) 0.96
A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo. Antimicrob Agents Chemother (2013) 0.95
Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold. BMC Complement Altern Med (2012) 0.94
In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition. Antiviral Res (2014) 0.91
Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1. Virol J (2012) 0.88
Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand. PLoS One (2011) 0.87
Non-specific microbicide product development: then and now. Curr HIV Res (2012) 0.85
First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics. J Acquir Immune Defic Syndr (2016) 0.82
Effect of acculturation on the acceptability of potential microbicides and sexual risk-taking. Sex Transm Dis (2009) 0.80
Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting. BMC Res Notes (2012) 0.79
The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model. PLoS One (2015) 0.79
Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial. AIDS Behav (2016) 0.76
In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel. Gynecol Oncol (2016) 0.75
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet (2008) 4.70
Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS One (2009) 3.66
Mental health problems among adults in tsunami-affected areas in southern Thailand. JAMA (2006) 3.25
Sex frequency and sex planning among men who have sex with men in Bangkok, Thailand: implications for pre- and post-exposure prophylaxis against HIV infection. J Int AIDS Soc (2010) 2.70
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clin Infect Dis (2009) 2.42
Leptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000. Emerg Infect Dis (2003) 2.35
Prevalence of and risk factors for methamphetamine use in northern Thai youth: results of an audio-computer-assisted self-interviewing survey with urine testing. Addiction (2002) 2.33
Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis (2002) 2.14
Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts. J Infect Dis (2001) 2.13
Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand. AIDS Res Hum Retroviruses (2003) 2.04
The contribution of family planning towards the prevention of vertical HIV transmission in Uganda. PLoS One (2009) 1.97
Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr (2002) 1.78
Palmtop-assisted self-interviewing for the collection of sensitive behavioral data: randomized trial with drug use urine testing. Am J Epidemiol (2005) 1.72
HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay. AIDS Res Hum Retroviruses (2003) 1.68
Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med (2013) 1.66
Acceptability of Carraguard vaginal gel use among Thai couples. AIDS (2006) 1.65
Increasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, Uganda. Malar J (2012) 1.65
Better than nothing or savvy risk-reduction practice? The importance of withdrawal. Contraception (2009) 1.62
Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews. J Clin Epidemiol (2008) 1.60
Evaluating programs to prevent mother-to-child HIV transmission in two large Bangkok hospitals, 1999-2001. J Acquir Immune Defic Syndr (2005) 1.54
Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection. J Infect Dis (2008) 1.53
Sexual initiation, substance use, and sexual behavior and knowledge among vocational students in northern Thailand. Int Fam Plan Perspect (2006) 1.49
Respondent-driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand. Drug Alcohol Depend (2007) 1.43
Rapid whole-blood finger-stick test for HIV antibody: performance and acceptability among women in northern Thailand. J Acquir Immune Defic Syndr (2003) 1.42
Enrollment characteristics and risk behaviors of injection drug users participating in the Bangkok Tenofovir Study, Thailand. PLoS One (2011) 1.40
HIV prevalence, risk behavior, hormone use and surgical history among transgender persons in Thailand. AIDS Behav (2011) 1.40
National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes. J Acquir Immune Defic Syndr (2009) 1.40
Comparative study between single dose 600 microg and repeated dose of oral misoprostol for treatment of incomplete abortion. Contraception (2004) 1.39
Effectiveness and acceptability of medical abortion provided through telemedicine. Obstet Gynecol (2011) 1.39
Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr (2010) 1.38
Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol (2002) 1.37
An outbreak of leptospirosis, Thailand--the importance of the laboratory. Southeast Asian J Trop Med Public Health (2005) 1.36
Association between HIV-1 infection, the etiology of genital ulcer disease, and response to syndromic management. Sex Transm Dis (2003) 1.36
Correlates of forced sex among populations of men who have sex with men in Thailand. Arch Sex Behav (2009) 1.36
Evidence of an explosive epidemic of HIV infection in a cohort of men who have sex with men in Thailand. AIDS (2013) 1.35
Self-induction of abortion among women in the United States. Reprod Health Matters (2010) 1.35
Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa. PLoS One (2011) 1.30
Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical Trial. J Acquir Immune Defic Syndr (2006) 1.30
Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis (2010) 1.29
Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS (2013) 1.25
Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up. AIDS (2011) 1.25
Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine (2004) 1.23
Airport exit and entry screening for Ebola--August-November 10, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.22
Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr (2011) 1.21
Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial. AIDS (2013) 1.19
Advance provision of emergency contraception for pregnancy prevention: a meta-analysis. Obstet Gynecol (2007) 1.13
Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003. Int J Drug Policy (2010) 1.11
Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. Pediatrics (2002) 1.11
Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting. Cerebrospinal Fluid Res (2009) 1.08
Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa. AIDS Behav (2009) 1.08
Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am J Respir Crit Care Med (2010) 1.08
Drug-eluting fibers for HIV-1 inhibition and contraception. PLoS One (2012) 1.08
Two-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibition. AIDS Behav (2008) 1.07
Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization. Sex Transm Dis (2006) 1.07
National program scale-up and patient outcomes in a pediatric antiretroviral treatment program, Thailand, 2000-2007. J Acquir Immune Defic Syndr (2010) 1.06
The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLoS One (2008) 1.06
Comparison of a clinical prediction rule and a LAM antigen-detection assay for the rapid diagnosis of TBM in a high HIV prevalence setting. PLoS One (2010) 1.06
Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings. Pediatr Infect Dis J (2009) 1.05
Assessment of service availability and health care workers' opinions about young women's sexual and reproductive health in Soweto, South Africa. Afr J Reprod Health (2012) 1.04
Evaluation of a new single-parameter volumetric flow cytometer (CyFlow(green)) for enumeration of absolute CD4+ T lymphocytes in human immunodeficiency virus type 1-infected Thai patients. Clin Diagn Lab Immunol (2005) 1.04
Male circumcision for HIV prevention: clinical practices and attitudes among healthcare providers in South Africa and Zimbabwe. Sex Transm Dis (2012) 1.03
Carraguard Vaginal Gel Safety in HIV-Positive Women and Men in South Africa. J Acquir Immune Defic Syndr (2007) 1.02
Integrating medical abortion into safe abortion services: experience from three pilot sites in South Africa. J Fam Plann Reprod Health Care (2008) 1.01
Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission? AIDS (2008) 1.01
The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS Behav (2008) 1.00
Directly observed therapy and improved tuberculosis treatment outcomes in Thailand. PLoS One (2008) 0.99
Systems for rapidly detecting and treating persons with ebola virus disease--United States. MMWR Morb Mortal Wkly Rep (2015) 0.99
Frequent human leukocyte antigen class I alleles are associated with higher viral load among HIV type 1 seroconverters in Thailand. J Acquir Immune Defic Syndr (2004) 0.98
Medicaid funding for abortion: providers' experiences with cases involving rape, incest and life endangerment. Perspect Sex Reprod Health (2010) 0.98
African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial. Sex Transm Dis (2011) 0.97
Genetic analysis of incident HIV-1 strains among injection drug users in Bangkok: evidence for multiple transmission clusters during a period of high incidence. J Acquir Immune Defic Syndr (2002) 0.97
An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India. AIDS Behav (2013) 0.97
Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003. Addiction (2009) 0.96
Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand. AIDS (2005) 0.96
Medical abortion: the possibilities for introduction in the public sector in South Africa. Reprod Health Matters (2005) 0.96
Sexual coercion among adolescents in northern Thailand: prevalence and associated factors. Southeast Asian J Trop Med Public Health (2003) 0.96
Complications after second trimester surgical and medical abortion. Reprod Health Matters (2008) 0.96
Cost-effectiveness analysis of unsafe abortion and alternative first-trimester pregnancy termination strategies in Nigeria and Ghana. Afr J Reprod Health (2010) 0.95
The epidemiology of HIV in South African workplaces. AIDS (2007) 0.95